These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 7476902

  • 1. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C, Connell Y, Neckers L.
    Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
    [Abstract] [Full Text] [Related]

  • 2. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
    Li BD, Budnick RM, Russo CA, Anderson GR, Stewart CC.
    J Surg Res; 1995 Oct; 59(4):485-92. PubMed ID: 7564322
    [Abstract] [Full Text] [Related]

  • 3. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
    Broaddus WC, Chen ZJ, Prabhu SS, Loudon WG, Gillies GT, Phillips LL, Fillmore H.
    Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
    [Abstract] [Full Text] [Related]

  • 4. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
    Galderisi U, Di Bernardo G, Melone MA, Galano G, Cascino A, Giordano A, Cipollaro M.
    J Cell Biochem; 1999 Jul 01; 74(1):31-7. PubMed ID: 10381259
    [Abstract] [Full Text] [Related]

  • 5. Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.
    Saijo Y, Uchiyama B, Abe T, Satoh K, Nukiwa T.
    Jpn J Cancer Res; 1997 Jan 01; 88(1):26-33. PubMed ID: 9045892
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.
    Iversen PL, Arora V, Acker AJ, Mason DH, Devi GR.
    Clin Cancer Res; 2003 Jul 01; 9(7):2510-9. PubMed ID: 12855625
    [Abstract] [Full Text] [Related]

  • 7. [Inhibition of c-sis protein synthesis and cell growth with antisense oligonucleotides in human glioma cells].
    Nitta T, Sato K.
    No Shinkei Geka; 1992 Aug 01; 20(8):857-63. PubMed ID: 1508312
    [Abstract] [Full Text] [Related]

  • 8. Elucidation of gene function using C-5 propyne antisense oligonucleotides.
    Flanagan WM, Su LL, Wagner RW.
    Nat Biotechnol; 1996 Sep 01; 14(9):1139-45. PubMed ID: 9631067
    [Abstract] [Full Text] [Related]

  • 9. Combination antigene therapy targeting c-myc and c-erbB(2) in the ovarian cancer COC(1) cell line.
    Fei R, Shaoyang L.
    Gynecol Oncol; 2002 Apr 01; 85(1):40-4. PubMed ID: 11925118
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
    Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI.
    J Clin Invest; 1994 Feb 01; 93(2):820-8. PubMed ID: 8113414
    [Abstract] [Full Text] [Related]

  • 11. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells.
    Yu BW, Nguyen D, Anderson S, Allegra CA.
    Anticancer Res; 1997 Feb 01; 17(6D):4407-13. PubMed ID: 9494542
    [Abstract] [Full Text] [Related]

  • 12. Enhanced in vivo tumour response from combination of carboplatin and low-dose c-myc antisense oligonucleotides.
    Walker TL, Dass CR, Burton MA.
    Anticancer Res; 2002 Feb 01; 22(4):2237-45. PubMed ID: 12174909
    [Abstract] [Full Text] [Related]

  • 13. Modulation of cellular functions in retroorbital fibroblasts using antisense oligonucleotides targeting the c-myc protooncogene.
    Heufelder AE, Bahn RS.
    Invest Ophthalmol Vis Sci; 1995 Jun 01; 36(7):1420-32. PubMed ID: 7775120
    [Abstract] [Full Text] [Related]

  • 14. A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer.
    Akie K, Dosaka-Akita H, Murakami A, Kawakami Y.
    Antisense Nucleic Acid Drug Dev; 2000 Aug 01; 10(4):243-9. PubMed ID: 10984118
    [Abstract] [Full Text] [Related]

  • 15. Antisense therapy of cancer.
    Narayanan R.
    In Vivo; 1994 Aug 01; 8(5):787-93. PubMed ID: 7727726
    [Abstract] [Full Text] [Related]

  • 16. Reduction of cisplatin cytotoxicity on human lung cancer cell lines with N-myc amplification by pretreatment with N-myc antisense oligodeoxynucleotides.
    Mizushima Y, Kashii T, Kobayashi M.
    Anticancer Res; 1995 Aug 01; 15(1):37-43. PubMed ID: 7733638
    [Abstract] [Full Text] [Related]

  • 17. Tumor genotype-specific growth inhibition in vivo by antisense oligonucleotides against a polymorphic site of the large subunit of human RNA polymerase II.
    Fluiter K, ten Asbroek AL, van Groenigen M, Nooij M, Aalders MC, Baas F.
    Cancer Res; 2002 Apr 01; 62(7):2024-8. PubMed ID: 11929820
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer.
    Dosaka-Akita H, Akie K, Hiroumi H, Kinoshita I, Kawakami Y, Murakami A.
    Cancer Res; 1995 Apr 01; 55(7):1559-64. PubMed ID: 7882365
    [Abstract] [Full Text] [Related]

  • 19. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G, D'Agnano I, Leonetti C, Perini R, Bucci B, Zon G, Calabretta B, Zupi G.
    Cancer Res; 1998 Jan 15; 58(2):283-9. PubMed ID: 9443406
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide.
    Watson PH, Pon RT, Shiu RP.
    Exp Cell Res; 1992 Oct 15; 202(2):391-7. PubMed ID: 1397092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.